B. Riley analyst Bryce Rowe lowered the firm’s price target on Oaktree Specialty Lending (OCSL) to $15 from $17 and keeps a Neutral rating on the shares post the fiscal Q3 report. The stock’s current price to net asset value of 86% is appropriate until NAV compression halts and a path to dividend coverage without fee waivers emerges, the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCSL:
- Oaktree Specialty Lending downgraded to Neutral from Overweight at JPMorgan
- Oaktree Specialty Lending Q4 2024 Earnings Overview
- Keefe lowers Oaktree Specialty target, says dividend at risk
- Oaktree Specialty Lending downgraded at JMP with fundamentals yet to stabilize
- Oaktree Specialty Lending downgraded to Market Perform at JMP Securities